255 results on '"Bolwell, Brian J."'
Search Results
2. Supplemental Table 1 from Impact of Chronic Graft-versus-Host Disease on Late Relapse and Survival on 7,489 Patients after Myeloablative Allogeneic Hematopoietic Cell Transplantation for Leukemia
3. Supplemental Figure 1 from Impact of Chronic Graft-versus-Host Disease on Late Relapse and Survival on 7,489 Patients after Myeloablative Allogeneic Hematopoietic Cell Transplantation for Leukemia
4. Supplemental Table 2 from Impact of Chronic Graft-versus-Host Disease on Late Relapse and Survival on 7,489 Patients after Myeloablative Allogeneic Hematopoietic Cell Transplantation for Leukemia
5. Supplemental Table 3 from Impact of Chronic Graft-versus-Host Disease on Late Relapse and Survival on 7,489 Patients after Myeloablative Allogeneic Hematopoietic Cell Transplantation for Leukemia
6. Supplemental Table 4 from Impact of Chronic Graft-versus-Host Disease on Late Relapse and Survival on 7,489 Patients after Myeloablative Allogeneic Hematopoietic Cell Transplantation for Leukemia
7. Chip-Derived Vs De Novo Treatment-Related Myeloid Neoplasms after Autologous Stem Cell Transplant for Lymphoid Disorders
8. Influence of Killer Immunoglobulin-Like Receptors and Somatic Mutations on Transplant Outcomes in Acute Myeloid Leukemia
9. The Power of Kindness
10. Joe Simone & Leadership
11. Straight Talk: Today's Cancer Centers: Meetings
12. Trust Revisited
13. Good Judgment
14. COVID-19 & Leadership
15. Genetic Counseling and Germline Testing in the Era of Tumor Sequencing: A Cohort Study
16. The Paradox of Empathy
17. Communication
18. Conditional Long-Term Survival after Autologous Hematopoietic Cell Transplantation for Diffuse Large B Cell Lymphoma
19. Interactions between Donor Activating Killer Immunoglobulin-like Receptors (KIRs) and Somatic Mutations and Their Association with Outcomes after Allogeneic Hematopoietic Cell Transplant for Acute Myeloid Leukemia (AML)
20. Values
21. Is Autologous Transplantation for Non-Hodgkin’s Lymphoma Underutilized?
22. Is Bone Marrow Transplantation Appropriate in Older Patients?
23. Conflict & New Tools
24. When Were You at Your Best?
25. It's Up to You
26. Low-Dose Lenalidomide After Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation With Bortezomib as Graft-Versus-Host Disease Prophylaxis in High-Risk Multiple Myeloma
27. Leadership
28. Leadership & Relationships
29. Clinical Factors Associated With Cost in Head and Neck Cancer: Implications for a Bundled Payment Model
30. Annual Meetings
31. Higher Risks of Toxicity and Incomplete Recovery in 13- to 17-Year-Old Females after Marrow Donation: RDSafe Peds Results
32. What We Do
33. Correction: Time to initial cancer treatment in the United States and association with survival over time: An observational study
34. Effect of Aging and Predonation Comorbidities on the Related Peripheral Blood Stem Cell Donor Experience: Report from the Related Donor Safety Study
35. On Criticism
36. Time to initial cancer treatment in the United States and association with survival over time: An observational study
37. Foresight
38. Let It Go
39. Intravenous compared to oral busulfan with cyclophosphamide for autologous hematopoietic cell transplant conditioning for plasma cell myeloma
40. Adolescent and Young Adult (AYA) Hematopoietic Cell Transplantation (HCT) Recipients Have Similar Quality of Life (QoL) Compared to Older Adults in the First Year Post-Transplantation
41. Risk Factors for Early Relapse after Allogeneic Hematopoietic Cell Transplantation in Acute Myeloid Leukemia
42. Comparative Effectiveness of Busulfan/Cyclophosphamide Versus Busulfan/Fludarabine Myeloablative Conditioning for Allogeneic Hematopoietic Cell Transplantation in Acute Myeloid Leukemia
43. Association of MHC Class I Chain-Related Gene a (MICA) Polymorphisms with Allogeneic Hematopoietic Cell Transplantation Outcomes in Acute Myeloid Leukemia
44. Givers & Takers
45. Precision Oncology in Solid Tumors: A Longitudinal Tertiary Care Center Experience
46. Related peripheral blood stem cell donors experience more severe symptoms and less complete recovery at one year compared to unrelated donors
47. Moments
48. On the Other Hand
49. Outcasts
50. Questions
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.